Chargement en cours...
Chimeric antigen receptors: driving immunology towards synthetic biology
The advent of second generation CARs and the CD19 paradigm have ushered a new therapeutic modality in oncology. In contrast to earlier forms of adoptive cell therapy, which were based on the isolation and expansion of naturally occurring T cells, CAR therapy is based on the design and manufacture of...
Enregistré dans:
| Publié dans: | Curr Opin Immunol |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5520666/ https://ncbi.nlm.nih.gov/pubmed/27372731 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coi.2016.06.004 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|